September 9, 2025 · Form 4 insider transaction
Reitan Colleen F sold 25 shares of Alnylam Pharmaceuticals, Inc. at $480.98 per share, a transaction worth $12.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025.